Monash IVF Group Limited: COVID-19 Update

Monash IVF Group Limited (ASX:MVF) notified the market that it supports the position of Fertility Society of Australia (FSA) and expects that the Company’s fertility activity would be hampered as patients postpone their treatment.

FSA recommends that patients should consult with their specialists and review the appropriateness of postponing the treatment.

MVF mentioned that it has enough headroom in existing banking covenants with cash on hand of nearly $25 million. The unused debt capacity with its current $115 million syndicated debt facility is due to mature after January 2022.

Comment


Disclaimer

Ad

GET A FREE STOCK REPORT


Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.


   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK